Fosaprepitant composition and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SPES PHARMA INC
- Publication Date
- 2021-01-19
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] priority claim
[0002] This application claims priority to U.S. Application No. 16 / 245,992, filed January 11, 2019, which claims priority to U.S. Provisional Application No. 62 / 673,522, filed May 18, 2018 Right, the entire content of said application is incorporated herein by reference in its entirety. technical field
[0003] The field of the invention and its embodiments relates to stable compositions of fosaprepitant or a pharmaceutically acceptable salt thereof. In particular, the present application relates to compositions of fosaprepitant dimeglumine that do not contain polysorbate 80 or similar surfactants. Methods of preparing such compositions are further described herein. Background technique
[0004] Fosaprepitant dimeglumine is an injectable drug sold by Merck Sharp & Dohme Corp. active pharmaceutical ingredients. Fosaprepitant is a water-soluble phosphorylated prodrug of aprepitant that is rapidly converted to aprepitant in vivo after intravenous (I...